
    
      A randomized, double-blind, placebo-controlled, phase I clinical trial to investigate the
      safety/tolerability and pharmacokinetics/pharmacodynamics of CKD-519 after oral
      administration in healthy adult volunteers Part I- single dosing / Part II- multiple dosing
    
  